GE Healthcare has teamed up with Vanderbilt University Medical Center to develop more precise cancer immunotherapy diagnostics that use artificial intelligence to predict both efficacy and potential side effects.
- Collaborating on 4 School of Medicine projects
- Five-year partnership
- Research activities include the development of multiple diagnostic tools using anonymized demographic, genomic, tumor, cellular, proteomic and imaging data from thousands of VUMC cancer patients.